NewsRoom Articles - Page 75 of 214

TuesdayApr 25, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aims to Complement its NanoAb Core Focus with Comprehensive Contract Development and Manufacturing Organization Services

BiondVax intends to expand its contract development and manufacturing organization (“CDMO”) offering as it continues the primary focus on its NanoAb pipeline development The CDMO services include aseptic fill and finish, upstream and downstream process development, as well as analytical model development and analytical testing This is made possible by BiondVax’s state-of-the-art assets in Jerusalem, Israel, including GMP-ready production clean rooms, fermentors, WFI, analytic tools, media, and buffer preparations With a combined 17 years of experience in recombinant protein process development from bench to Phase 3, BiondVax’s boutique CDMO service is well positioned to meet client needs BiondVax Pharmaceuticals (NASDAQ:…

MondayApr 24, 2023 1:36 pm

NIH Research Links Eczema Onset to Air Pollution

New research has found that pollutants found in the air may cause eczema in infants. Eczema, also referred to atopic dermatitis, is a condition that causes an individual’s skin to become itchy and extremely dry. This skin condition affects more than 31 million Americans. Eczema often develops in infancy and peaks in early childhood. However, flare-ups may occur even in adults when an individual comes into contact with allergens such as dyes, pets, perfumes or even food. While it is common knowledge that genetics may make one more susceptible to developing eczema, researchers are yet to determine its exact cause.…

FridayApr 21, 2023 2:48 pm

Study Finds That Different Subtypes of Epilepsy Trigger Different Autoimmune Conditions

Scientists may have identified a pair of epilepsy syndrome patterns and their link to autoimmune illnesses. The single-center study was carried out between January 2016 and December 2020 and involved patients at a tertiary epilepsy center. During this period, the researchers gathered data from 242 patients suffering from mesial temporal lobe epilepsy with hippocampal sclerosis and 422 patients with idiopathic generalized epilepsies (IGEs). The researchers observed that, on average, patients who suffered from idiopathic generalized epilepsies were more than a decade younger than those with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) They also noted that autoimmune disease prevalence…

FridayApr 21, 2023 9:00 am

Progressive Care Inc. (RXMD) Technology Solutions May Spark Rapid Expansion

RMXD news indicates that a synergistic tech-healthcare collaboration with potential to ignite both growth and revenues is in the works “Restructuring whiz” takes the helm as CEO, board chair Through technology and proven processes, Progressive Care helps simplify chaos, improve care and reduce costs Recent developments bode well for the future of Progressive Care (OTCQB: RXMD). On a mission to snag ever more market share using data management and analytical tools, the well-established healthcare company might be on the cusp of breaking out of slow-growth mode and into rapid expansion. Several factors are at play that could prove meaningful for…

ThursdayApr 20, 2023 10:57 am

Mechanical Nanosurgery Could Revolutionize Brain Cancer Treatment

Glioblastoma is an aggressive brain cancer that invades brain tissue. The average life expectancy following diagnosis for this cancer is 14 to 16 months. Globally, the standard of care for patients with this type of cancer includes chemotherapy with temozolomide, which extends a patient’s expectancy by about two months. Patients may also undergo radiotherapy as well as surgery to remove tumors. However, even after rigorous treatment cycles, glioblastoma cells may develop resistance to temozolomide over time, heightening the chances of tumor relapse and decreasing its effectiveness. Researchers at the University of Toronto and The Hospital for Sick Children may have…

ThursdayApr 20, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leads Biotechnology Frontier with Experienced Leadership Team

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK, and Bristol-Myers Squibb The team has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza candidate, and built, owns, and operates its GMP biologics manufacturing facility BiondVax has an exclusive collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (“MPG”) and the University Medical Center Göttingen (“UMG”), to develop a pipeline of innovative nanosized antibody therapies BiondVax’s experience, assets, and pipeline represent a rare opportunity for a company of its size BiondVax Pharmaceuticals (NASDAQ: BVXV), a…

WednesdayApr 19, 2023 2:40 pm

Allergic Reactions Caused by Gel Nail Polishes on the Rise

A survey of 742 individuals found that 16% had experienced serious reactions to gel polish. A warning on this issue was first issued in 2018 by the British Association of Dermatologists following reports of a significant increase in allergic skin reactions linked to the chemicals. Dermatologists recently brought the issue to light again, noting the steep rise in the number of individuals who develop allergies caused by gel nail polishes seeping into their skin. The warning notes that the chemicals found in these products may cause a serious, itchy rash to develop on one’s skin as well as loosen the…

TuesdayApr 18, 2023 1:21 pm

How Pharmacies Should Prepare for Future Health Care Landscape

The healthcare landscape has changed significantly, especially since the coronavirus pandemic, and will continue to do so as technology advances. The pandemic highlighted how crucial pharmacists were in keeping individuals healthy. It has also become clear that pharmacies help mold health outcomes in a number of ways. However, to successfully move forward in the industry, pharmacies will need to step it up a notch or two. They can start to do so by considering how certain changes may affect their daily operations and make the necessary adjustments. For instance, the shift toward value-based care models is important to consider as…

TuesdayApr 18, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Presents Innovative Pipeline of Nanosized Antibody Treatments at Bio-Europe Spring Conference in Switzerland

BiondVax participated in the life science industry’s 17th annual Bio-Europe Spring Conference, held this year in Switzerland BiondVax was highlighted as one of the “best ideas” in a NASDAQ-published article after the completion of the conference The company’s biobetter nanosized antibody therapies promise stability at high temperatures, superior binding affinity, convenient routes of administration, and cost effective production The EBD Group’s 17th annual Bio-Europe Spring Conference was held March 20-22, 2023, in Basel, Switzerland. The conference showcased three thematic pillars - the business of biotech, therapeutic insight tracks, and ecosystem influencers. The elite European bio-tech conference featured a mix of…

MondayApr 17, 2023 1:32 pm

Biden Signs Measure to End National COVID-19 Emergency

Earlier this week, President Joseph Biden signed a bill that would end the COVID-19 national emergency with immediate effect. The national emergency was first enacted in 2020, during former President Donald Trump’s administration. Initially, the White House had announced plans to extend the national emergency as well as the public health emergency until May 11, 2023. However, GOP members in the House introduced measures to end both immediately. In a statement of administration policy, the White House stated that a sudden end to the emergency proclamations would cause uncertainty and chaos throughout the healthcare system. This is primarily because these…